Evidence map›Paper›PMID 40138134›Full record

ArticleApplied biochemistry and biotechnology2025

Engineering Escherichia coli for Efficient Production of L-Tryptophan.

Song Yang, Shengyu Zhou, Quanfeng Liang, Yi Wang, Wei Luo

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Song YangThe Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, 214122, China.
Shengyu ZhouThe Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, 214122, China.
Quanfeng LiangState Key Laboratory of Microbial Technology, Shandong University, Qingdao, 266237, PR China.
Yi WangDepartment of Biological and Agricultural Engineering, University of California, Davis, 1 Shields Ave, Davis, CA, 95616, USA.
Wei LuoThe Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, 214122, China. wluo@jiangnan.edu.cn.

Funding

State Key Laboratory of Microbial Technology Open Projects Fund M2024-11
6 · The paper itself

Abstract

L-tryptophan is an essential amino acid widely used in animal feed, food additives, and pharmaceuticals. Although the biosynthesis of L-tryptophan from renewable raw materials is sustainable and environmentally friendly, its long synthetic pathway and complex regulatory mechanisms often result in low production efficiency. In this study, multiple strategies were employed to improve L-tryptophan production in Escherichia coli. These strategies included three main ones: the introduction of anti-feedback inhibition mutations, the overexpression of key rate-limiting enzymes, and the blockage of competitive and catabolic pathways. Additionally, the glucose transport system was modified by replacing it with a non-phosphoenolpyruvate (PEP)-dependent system, thereby reducing PEP consumption. In addition, overexpression of an L-tryptophan transporter protein enhanced L-tryptophan efflux and alleviated product inhibition. Consequently, an efficient L-tryptophan-producing E. coli strain was constructed. Furthermore, dynamic regulation of L-tryptophan synthesis was initially explored by employing a temperature-sensitive promoter to modulate the PEP metabolic pathway. Scale-up fermentation in a 5-L bioreactor demonstrated that the final strain (TY9) produced 34.1 g·L

Indexed as

Escherichia coliMetabolic EngineeringTryptophanBioreactorsFermentationGlucoseGlucoseTryptophanCombined strategiesEscherichia coliL-tryptophanMetabolic engineering

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.